DAP divergent transcript (DAP-DT)

DAP divergent transcript (DAP-DT, CTD-2154B17.4) is an RNA gene described as a divergent transcript, meaning it is likely transcribed from the opposite DNA strand near a promoter region of another gene. Divergent transcription is a widespread phenomenon where noncoding RNAs are produced from genomic regions adjacent to protein-coding genes, often forming unstable and short RNA molecules[1]. The biological significance of most divergent transcripts, including DAP-DT, remains largely unknown. Available gene databases list DAP-DT as a non-protein-coding RNA gene, with no established function, pathway associations, or disease roles[5]. There is insufficient information to consider DAP-DT as a bona fide therapeutic target, and its role—if any—in disease, drug interaction, or as a biomarker is currently uncharacterized[5][2]. Essential context and rationale: - The term "divergent transcript" refers to a class of noncoding RNAs transcribed in a direction opposite to a nearby coding gene; their function is usually unclear[1]. - GeneCards and similar databases list DAP-DT only as an RNA gene, with very limited or no annotated function, interaction, or disease relevance[5][2]. - There is no evidence that DAP-DT is a drug target or relevant in current therapeutic strategies. Most divergent transcripts do not encode proteins, and their biological roles are commonly either unproven or minimal[1]. - This entry is considered "incorrect" as a pharmacotherapeutic target and should not be treated as such for purposes of drug development, biomarker research, or clinical relevance. If you require structured information for a known therapeutic target, please provide a well-characterized protein-coding gene, receptor, enzyme, or other established target name.

Other names

DAP-DTCTD-2154B17.4